- Home
- /Hemoglobin observations newborn screening panel
Hemoglobin observations newborn screening panel
Measures hemoglobin types and levels in newborn blood to detect blood disorders.
Why This Biomarker Matters
Early detection of hemoglobinopathies like sickle cell disease enables prompt treatment, preventing life-threatening complications and improving long-term outcomes for affected infants.
Overview
This newborn screening panel measures hemoglobin types and levels from a blood spot collected from heel pricks. It detects sickle cell disease, thalassemia, and other hemoglobinopathies that affect oxygen-carrying capacity. Early detection allows immediate treatment to prevent serious complications like pain crises, organ damage, and stroke. This screening is performed on all newborns in most countries and is critical for infant health outcomes.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
64116-7PrimaryAvailable Lab Tests
Order tests that measure this biomarker